Comparative effectiveness and safety of ribavirin plus interferon-alpha, lopinavir/ritonavir plus interferon-alpha, and ribavirin plus lopinavir/ritonavir plus interferon-alpha in patients with mild to moderate novel coronavirus disease 2019: study protocol

Guardat en:
Dades bibliogràfiques
Publicat a:Chin Med J (Engl)
Autors principals: Zeng, Yan-Ming, Xu, Xiao-Lei, He, Xiao-Qing, Tang, Sheng-Quan, Li, Yao, Huang, Yin-Qiu, Harypursat, Vijay, Chen, Yao-Kai
Format: Artigo
Idioma:Inglês
Publicat: Wolters Kluwer Health 2020
Matèries:
Correspondence
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7213617/
https://ncbi.nlm.nih.gov/pubmed/32149772
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CM9.0000000000000790
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars